Form 8-K Arch Therapeutics, Inc. For: May 12 – StreetInsider.com

UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. FORM 8-K. CURRENT REPORT. Pursuant to Section 13 OR 15(d) …